Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 95 shares, an increase of ∞ from the July 15th total of 0 shares. Based on an average daily trading volume, of 2 shares, the short-interest ratio is presently 47.5 days.
Embla Medical hf. Price Performance
Shares of Embla Medical hf. stock opened at $4.15 on Friday. The business has a 50 day simple moving average of $4.15 and a two-hundred day simple moving average of $4.35. Embla Medical hf. has a 12 month low of $4.15 and a 12 month high of $5.33.
About Embla Medical hf.
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
See Also
- Five stocks we like better than Embla Medical hf.
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
